Media centerClara Prieto2023-11-23T09:45:37+01:00

MEDIA CENTER

Keep up to date with our latest news and resources

PRESS RELEASES

Catch up with the latest updates from our company

mAbxience and Abdi İbrahim Announce Landmark Technology Transfer Agreement, Advancing Biotechnology in Türkiye

Miguel Martínez-Cava2023-11-20T08:43:23+01:00November 20, 2023|Press releases|

mAbxience and MS Pharma Sign Partnership for Denosumab Biosimilar in Select MEA Countries

Miguel Martínez-Cava2023-11-13T07:53:41+01:00November 13, 2023|Press releases|

mAbxience and Amneal Strengthen Alliance with Two Denosumab Biosimilars in the U.S. for the Treatment of Oncology and Bone Diseases

Clara Prieto2023-10-21T14:44:19+02:00October 12, 2023|Press releases|

BLOG

Dive into the insights from mAbxience, written by our team

Boosting biologics and Contract Manufacturing at mAbxience facilities

Comunicacion Admon2023-04-03T09:26:50+02:00April 3, 2023|News|

HK inno.N licenses in mAbxience’s denosumab biosimilar

theoms2023-01-25T10:46:18+01:00January 25, 2023|News|

mAbxience II Biosimilar Forum

theoms2022-10-26T13:44:17+02:00October 26, 2022|News|

MULTIMEDIA

Browse our media resources and materials

mAbxience | INFOGRAPHIC

Similarity Exercise | VIDEO

mAbxience Biosimilar Development | VIDEO

mAbxience León site | VIDEO

mAbxience Argentina | VIDEO

mAbxience | VIDEO